96724 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
FORMULATION OF MODIFIED INTERLEUKIN-7 FUSION PROTEIN
#2THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
#3MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION
#4PEPTIDE-COMPOUND CYCLIZATION METHOD
#5THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
#6DELIVERY OF ENDOTHELIAL CELL-LADEN MICROGEL ELICITS ANGIOGENESIS IN SELF-ASSEMBLING ULTRASHORT PEPTIDE HYDROGELS
#7FORMULATION OF MODIFIED INTERLEUKIN-7 FUSION PROTEIN
#8MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#9COMPOSITIONS AND METHODS FOR TREATING NERVOUS SYSTEM INJURIES
#10SYNTHETIC COMPOUND
#11INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES
#12PROCESS AND INTERMEDIATES FOR SYNTHESIS OF PEPTIDE COMPOUNDS
#13SALT AND CRYSTALLINE FORMS OF RAPASTINEL
#14SARS-CoV-2 epitope-targeted peptide immunostimulants
#15Peptide-compound cyclization method
#16THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
#17Compounds and compositions for targeting brain injuries and methods of use thereof
#18DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-LGR7 ANTIBODY
#19Peptide capable of forming a gel for use in tissue engineering and bioprinting
#20Micropeptides and use of same for modulating gene expression
#21MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION
#22INSULIN A-CHAIN DERIVED PEPTIDE FRAGMENT AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES OR DIABETIC WOUNDS, CONTAINING THE SAME
#23Synthetic compound
#24THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
#25NDMA RECEPTOR MODULATORS AND USES THEREOF
#26PAR2 mimetic peptides and uses thereof
#27Method for identifying a modulator of cell survival or plasticity
#28METHODS OF TREATING DEPRESSION AND OTHER RELATED DISEASES
#29Formulation of modified interleukin-7 fusion protein
#30MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#31Therapy and kit for the prevention and treatment of cystic fibrosis
#32Compounds and compositions for targeting brain injuries and methods of use thereof
#33N-METHYL-D-ASPARTATE RECEPTOR MODULATORS AND METHODS OF MAKING AND USING SAME
#34NMDA RECEPTOR MODULATORS AND USES THEREOF
#35METHOD FOR PREPARATION OF N-ACYL PEPTIDES, POLYPEPTIDES AND PROTEINS
#36Cahuitamycins and methods of making and using the same
#37Methods of treating depression and other related diseases
#38Inhibitors of growth factor activation enzymes
#39VERSATILE PEPTIDE-BASED MULTI-ARM LINKERS FOR CONSTRUCTING PHARMACEUTICAL MOLECULES
#40Therapeutic agents for reducing parathyroid hormone levels
#41SFRP5-derived peptide fragment and cosmetic composition for skin whitening containing same
#42Functionalized titanium binding peptides and implants coated with same
#43LINEAR PEPTIDE ANTIBIOTICS
#44N-methyl-D-aspartate receptor modulators and methods of making and using same
#45Macrocyclic broad spectrum antibiotics
#46Sfrp5-derived peptide fragment and cosmetic composition for skin whitening containing same
#47Synthetic peptides, enzymatic formation of pericellular hydrogels/nanofibrils, and methods of use
#48Neurogenic brain-derived neurotrophic factor peptides
#49Surface-binding peptide
#50NMDA Receptor Modulators and Uses Thereof
#51PEPTIDE-COMPOUND CYCLIZATION METHOD
#52MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION
#53Modified peptides as potent inhibitors of the PSD-95/NMDA receptor interaction
#54Therapeutic agents for reducing parathyroid hormone levels
#55Compositions and methods of treatment of cancers
#56Deprotection method
#57Methods of treating depression and other related diseases
#58Hepatitis C virus inhibitors
#59Short bio-active peptides for promoting wound healing
#60Anti-inflammatory proteins and peptides and methods of preparation and use thereof
#61NMDA Receptor Modulators and Uses Thereof
#62Mucin hypersecretion inhibitors and methods of use
#63Compounds and method for treating or preventing disease conditions associated with alpha-1-antitrypsin
#64Therapy and kit for the prevention and treatment of cystic fibrosis
#65Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#66Therapeutic agents for reducing parathyroid hormone levels
#67Linear peptide antibiotics
#68Compounds and methods for inhibiting cell death
#69Compositions and methods for increasing carnitine level in muscle tissue
#70Glutathione-elevating compositions and uses thereof
#71Functionalized titanium binding peptides and implants coated with same
#72Method for producing a recombinant peptide and resultant peptide
#73Niacin-peptide having skin whitening activity and use for same
#74Macrocyclic compounds for suppressing replication of hepatitis C virus
#75Eye drops
#76Selective caspase inhibitors and uses thereof
#77Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#78Hybrid polypeptides with selectable properties
#79Template-fixed peptidomimetics
#80Combination therapy and kit for the prevention and treatment of cystic fibrosis
#81sGCalphal inhibiting compositions
#82Neuroprotective and neurorestorative methods and compositions
#83Neurogenic brain-derived neurotrophic factor peptides
#84Methods and compositions related to internalizing RGD peptides
#85Mucin hypersecretion inhibitors and methods of use
#86Methods of treating depression and other related diseases
#87Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#88Methods of treating depression and other related diseases
#89Smart pro-drugs of serine protease inhibitors
#90Methods of treating depression and other related diseases
#91Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
#92Small peptides and methods for blocking IGE mediated activation of an immune cell
#93Compounds and methods for treating or preventing disease conditions associated with α-1-antitrypsin
#94Linear peptide antibiotics
#95Therapeutic agents for reducing parathyroid hormone levels
#96Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species
#97Aziridine mediated native chemical ligation
#98PEPTIDES FOR THE REGULATION OF NEUROTRANSMITTER SEQUESTRATION AND RELEASE
#99COMPOSITIONS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN CFTR AND CAL
#100NMDA receptors modulators and uses thereof
#101Methods of treating depression and other related diseases
#102Methods of treating depression and other related diseases
#103Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
#104REGULATION OF AUTOPHAGY PATHWAY PHOSPHORYLATION AND USES THEREOF
#105Hybrid polypeptides with selectable properties
#106Phalloidin derivatives and methods for their synthesis
#107THERAPEUTIC AGENT FOR GASTROINTESTINAL DISEASE
#108Glycopegylation methods and proteins/peptides produced by the methods
#109Therapeutic agents for reducing parathyroid hormone levels
#110Eye drops
#111High penetration prodrug compositions of peptides and peptide-related compounds
#112ANTIMICROBIAL, ANTIVIRAL, ANTICANCER AND IMMUNOMODULATORY PEPTIDES AND USES THEREFORE
#113Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
#114Prodrugs
#115Compositions and methods for inhibiting the interaction between CFTR and CAL
#116Therapeutic and diagnostic conjugates for use with multispecific antibodies
#117Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
#118Neuroprotective and neurorestorative method and compositions
#119Rapid FRET-based diagnosis of bacterial pathogens
#120SYNTHETIC PEPTIDE AND USES THEREOF
#121Diagnosis and Treatment of Cancer Using Anti-LGR7 Antibody
#122VAULT AGENTS FOR CHRONIC KIDNEY DISEASE
#123Cysteine-free efficient Technetium (Tc) or Rhenium (Re) chelating peptide tags and their use
#124Novel HCV core+1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents
#125METHODS AND SYSTEMS TO DETECT AN ACTIVE PROTEASE IN A SAMPLE
#126FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS
#127Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
#128Small molecule inhibitors of MUC1 and methods of identifying the same
#129THYMOSIN Beta4 PEPTIDES PROMOTE TISSUE REGENERATION
#130Oligomeric biosurfactants in dermatocosmetic compositions
#131MULTI-COMPONENT ANTIOXIDANT COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE FOR REDUCING OR PREVENTING OXIDATIVE STRESS
#132Modified peptides as potent inhibitors of the PSD-95/NMDA receptor interaction
#133Gene regulator
#134ATTRACTIN/MAHOGANY-LIKE POLYPEPTIDES, POLYNUCLEOTIDES, ANTIBODIES AND METHODS OF USE THEREOF
#135Selective caspase inhibitors and uses thereof
#136Methods for treating a skin wound
#137PROTEIN VARIANTS HAVING MODIFIED IMMUNOGENICITY
#138Therapeutic agents for reducing parathyroid hormone levels
#139Substrate for assaying β-glucan and/or endotoxin and assay method
#140Mass tags for quantitative analyses
#141Treatment of burns
#142METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION
#143Therapeutic peptides and uses thereof
#144METHODS FOR THE PREPARATION OF FUNCTIONALIZED PEPTIDES, PROTEINS AND CARBOHYDRATES AND THEIR CONJUGATES
#145Mucin hypersecretion inhibitors and methods of use
#146Smart Pro-Drugs of Serine Protease Inhibitors
#147ASSESSMENT OF CANCER SUSCEPTIBILITY TO MOLECULAR TARGETED THERAPY BY USE OF RECOMBINANT PEPTIDES
#148METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF INFLUENZA
#149Template-fixed peptidomimetics
#150Peptides for the regulation of neurotransmitter sequestration and release
#151REGULATION OF APG8 PHOSPHORYLATION AND USES THEREOF
#152Regulation of autophagy pathway phosphorylation and uses thereof
#153Glycopegylation methods and proteins/peptides produced by the methods
#154PROCESS FOR DETECTING ENZYME ACTIVITY IN AN IMMUNOASSAY
#155Methods of inhibiting osteoclast activity
#156NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES
#157Mucin hypersecretion inhibitors and methods of use
#158Enhancing the circulating half-life of antibody-based fusion proteins
#159Selective substrates for matrix metalloproteinases
#160Synthetic Ligands Able to Bind Ochratoxin A and Uses Thereof
#161Methods and compositions related to internalizing RGD peptides
#162Method for producing peptide thioester
#163Treatment methods using peptides related to amyloid precursor protein
#164Methods and uses for protein breakdown products
#165Methods For Immuno-Detection Of Epitopes On Molecules And For Detection Of Interactions Of Molecules Via Fluorescent Dyes
#166Alpha-fetoprotein peptides
#167OMI PDZ MODULATORS
#168Diagnostic and therapeutic agents
#169Peptide inhibiting angiotensin converting enzyme
#170PEPTIDES FOR USE IN CULTURE MEDIA
#171Anti-cancer compounds
#172Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use
#173METHODS AND COMPOSITIONS FOR TREATING CONDITIONS
#174Novel Polypeptide Ligands For Toll-Like Receptor 2 (TLR2)
#175Attractin/mahogany-like polypeptides
#176Methods for treating a corneal disorder and promoting skin wound healing
#177Immunoregulatory compositions
#178Substrates and assays for beta-secretase activity
#179Peptide compositions
#180Small peptides and methods for inhibiting the infiltration of eosinophils into airways
#181Small Peptides And Methods For Inhibiting The Migration Of T-Cells
#182Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
#183Small peptides and methods for inhibiting mucus release into airways
#184Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
#185Small Peptides And Methods For Treatment Of Chronic Obstruction Pulmonary Disease
#186Small Peptides And Methods For Treatment Of Arthritis
#187NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES
#188Small Peptides And Methods For Stabilizing The Cell Membrane Of An Immune Cell
#189Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species
#190Gene regulator
#191Treatment of burns
#192Treatment methods using polypeptides related to amyloid precursor protein
#193EPITOPES FORMED BY NON-COVALENT ASSOCIATION OF CONJUGATES
#194Antihypertensive Peptides
#195Substrates and Assays for Beta Secretase Activity
#196IMMUNOREGULATORY COMPOSITIONS
#197Alpha-fetoprotein peptides and uses thereof
#198Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
#199Conjugates useful in the treatment of prostate cancer
#200Compositions capable of reducing elevated blood urea concentration
#201Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
#202Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier
#203Conformationally restricted polyamine analogs as disease therapies
#204Methods and compositions for diagnosis and treatment of influenza
#205Conjugates useful in the treatment of prostate cancer
#206Treatment of ischemic events
#207Mass tags for quantitative analyses
#208Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
#209Antimicrobial peptides and utilization of the same
#210Peptides and mimetics for reducing symptoms of toxic shock syndrome and septic shock
#211Glycopegylation methods and proteins/peptides produced by the methods
#212Conjugates useful in the treatment of prostate cancer
#213Hybrid polypeptides having glucose lowering activity
#214Method of designing physiologically active peptide and use thereof
#215Intracellular delivery of biological effectors
#216Mucin hypersecretion inhibitors and methods of use
#217HCV core+1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents
#218Anti-cancer compounds
#219Intracellular delivery of biological effectors
#220Heparin-binding peptides and uses thereof
#221Conjugates useful in the treatment of prostate cancer
#222Ultra-high specificity fluorescent labeling
#223Reagents and procedures for multi-label high-specificity labeling
#224Fluorogenic enzyme assay methods, kits and compositions using charge-balancers
#225Antimicrobials against pathogenic bacteria and method for screening them
#226Hybrid polypeptides with selectable properties
#227Smart pro-drugs of serine protease inhibitors
#228Peptides for use in culture media
#229Luciferyl peptide substrate
#230Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
#231Neurotrophic and neuroprotective peptides
#232Enhancing the circulating half-life of antibody-based fusion proteins
#233Cloning and expression of recombinant adhesive protein Mefp-1 of the blue mussel,
#234Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
#235Omi PDZ modulators
#236Attenuation of metapneumovirus
#237Molecular interactions in cells
#238Peptides and their use to ameliorate cell death
#239IL-16 antagonists
#240Immunoglobulin chimeric monomer-dimer hybrids
#241Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
#242Methods and compositions for treating leukemia
#243Gene regulatory peptides
#244Peptides for use in culture media
#245Selective substrates for matrix metalloproteinases
#246Protein variants having modified immunogenicity
#247Compounds and methods for modulating functions of classical cadherins
#248Carboxamide and amino derivatives and methods of their use
#249Carboxamide and amino derivatives and methods of their use
#250Substrates and assays for beta-secretase
#251Methods of inhibiting osteoclast activity
#252Linear and cyclic melanocortin receptor-specific peptides
#253Method of purifying TFPI and TFPI analogs
#254Novel biomarkers of aggrecanase activity
#255Methods and uses for protein breakdown products
#256Peptides comprising furanoid sugar amino acids for the treatment of cancer
#257Vaccine compositions and methods
#258Quinones as disease therapies
#259Peptide containing Ser-Ser-Ser-Arg
#260Therapeutic and diagnostic conjugates for use with multispecific antibodies